24 results
8-K
EX-4.2
ALGS
Aligos Therapeutics Inc
25 Oct 23
Entry into a Material Definitive Agreement
5:05pm
as reported by Bloomberg Financial Markets (or a comparable reporting service of national reputation selected by the Company and reasonably acceptable
424B4
e0d nxm7f63r6c
1 Jul 21
Prospectus supplement with pricing info
4:31pm
DRS
j5k9muejd
4 Jun 21
Draft registration statement
12:00am
10-K
9kzqm
23 Mar 21
Annual report
4:26pm
10-Q
od2t2s 8e
25 Nov 20
Quarterly report
5:21pm
424B4
895oxzy 7hcyt1ioh
19 Oct 20
Prospectus supplement with pricing info
5:21pm